OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Blaine Roberts

3 Projects | 1 Researchers | $828,777 Invested

2020

NeuroVision Imaging, Inc.

Blaine Roberts, PhD

Validation of blood based biomarkers for the detection of brain amyloid accumulation before clinical onset of dementia.

  • Funding Amount: $539,259
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Closed

2017

Florey Institute of Neuroscience and Mental Health

Blaine Roberts, PhD

Plasma Abeta protein complexes for the early detection of brain amyloid accumulation.

  • Funding Amount: $149,518
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2013

Florey Institute of Neuroscience and Mental Health

Blaine Roberts, PhD

Validation of an effective blood test for Alzheimer's disease.

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed